Category Archives: Events

Latest From Events

BIO Investor Forum Company Snapshot: NovelMed Therapeutics

NovelMed

NovelMed Therapeutics will be presenting at the upcoming BIO Investor Forum in October in San Francisco. Read below to learn more about their antibodies portfolio, what differentiates their company for the competition, and other interesting facts about the company. Company Snapshot What is your company’s lead product or technology? NovelMed has developed a portfolio of fully humanized monoclonal antibodies that selectively target only the disease-associated Complement System. As such, NovelMed’s antibodies are active against multiple Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIO Investor Forum Company Snapshot: MAX BioPharma

maxbiopharma

Earlier this week, we featured a presenting company for our upcoming BIO Investor Forum event in San Francisco in our ‘company snapshot‘ feature. For our next post, we spoke to MAX BioPharma, who will be giving a presentation in our Discovery Company presentation track, which features companies in their Seed or Series A financing rounds, with under 25 million raised to date. Read on to learn more about this Discovery Company.   Company Snapshot What Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Investor Forum Company Snapshot: AM-Pharma

AM Pharma

The BIO Investor Forum will be taking place this October in San Francisco for its 12th annual event. So far this year, the hot topic is, of course, the hot market. Out of all the therapeutic US companies that have had an IPO in 2013, 71% of them have attended the BIO Investor Forum. The program for the event will thus feature two great panels about the recent IPO activity, in addition to other therapeutic workshops Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Investor Forum Veterans Moving Up with the Recent Biotech Deal Surge

150639480

As detailed in The New York Times, the potential for deal-making in the industry has resulted in a big surge in the biotech sector. According to the article, last month alone, seven companies completed I.P.O’s and at least five are lined up behind them. Furthermore, according to data provided by NASDAQ, all 16 of the biotechnology companies that have gone public this year are up 48 percent on average from their offering prices. In fact Read More >

Events  |  Leave a comment  |  Email This Post
Tags:

Everyone is Engaging with China’s Biotech Industry, Including BIO

biochina-flag-btn

Countries all over the world are recognizing the importance of biotechnology to their economies, the health and well-being of their citizens, their food supply and their ability to generate clean energy. Nearly every major country has adopted programs to generate a homegrown biotechnology sector and the well-paying jobs it supports. China is no exception. China has included biotechnology as one of seven strategic priorities for scientific and technological development in its 12th Five-Year Plan and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,